Excellent Paper Award Winner; “Latest Treatment Options to Overcome Acquired Resistance to Osimertinib for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) After Prior EGFR-TKI Therapies”, Tam Q. Nguyen, Paul E. Lie, Donald Y.C. Lie and Lukman Tijani, Proc. International Conference on Medical and Biosciences (ICMBS) Taipei , Taiwan June 26-27, 2019

Research output: Contribution to conferencePaperpeer-review

Original languageEnglish
StatePublished - 2019

Fingerprint Dive into the research topics of 'Excellent Paper Award Winner; “Latest Treatment Options to Overcome Acquired Resistance to Osimertinib for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) After Prior EGFR-TKI Therapies”, Tam Q. Nguyen, Paul E. Lie, Donald Y.C. Lie and Lukman Tijani, Proc. International Conference on Medical and Biosciences (ICMBS) Taipei , Taiwan June 26-27, 2019'. Together they form a unique fingerprint.

Cite this